Radar · Biopharma Outsourcing in England
Best Biopharma Outsourcing Companies in England, United Kingdom
The 415 best Biopharma Outsourcing companies in England, United Kingdom in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Oxford BioMedica.
By Riya SenguptaFinancials
415companies tracked
$1.3Bdisclosed funding
0unicorns
122have raised
FLIAR INTELLIGENCE · BIOPHARMA OUTSOURCING × ENGLAND
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
100companies analysed
68%cloud-native stacks
2025funding peak (by rounds)
2008median founding year
50median Fliar Index™
332kcombined LinkedIn audience
35%of audience held by top 3
9companies hiring publicly (12 mo)
Ranked: Best Biopharma Outsourcing companies in England
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Oxford BioMedica Manufacturer of viral vectors for cell and gene therapy products | $150M | 10 mo ago | 815 815 → 933 (+14%) · sector median +14% | 1995 | Neill Mackenzie Founder | 427 patents Lentiviral vector design, production, and purification for gene‑therapy applications | — |
| 2 | Ascend Provider of drug research & development and clinical trial services for cell & gene therapeutic services | $132M | 39 mo ago | 92 | 2021 | — | — | — |
| 3 | Vernalis Drugs for the treatment of cough, asthma, migraine and cancer. | $132M | 121 mo ago | 85 | 1999 | — | 1,306 patents Small-molecule oncology drugs targeting apoptosis regulators and kinases (Bcl‑xL, Mcl‑1, LRRK2). | — |
| 4 | Abzena Provider of antibody discovery, cell line development, and bio analytics services | $69M | 50 mo ago | 306 306 → 444 (+45%) · sector median +14% | 2001 | Jonathan Goldman CEO | 9 patents Therapeutic antibody-drug conjugates targeting PSMA for cancer treatment | — |
| 5 | Quotient Bioresearch CRO providing early stage drug development services and consulting | $62M | 213 mo ago | 200 | 1992 | — | 2 patents Biomolecule recovery processes for biopharmaceutical manufacturing | — |
| 6 | eXmoor Provider of cell & gene therapautic services for biopharmaceutical sector | $52M | 36 mo ago | 80 | 2004 | — | — | — |
| 7 | Alliance International consumer healthcare business managing brands and partnerships | $45M | 95 mo ago | 249 249 → 521 (+109%) · sector median +14% | 1998 | Peter Butterfield CEO | 15 patents Food processing (chocolate formulation) and financial trading/liquidity management software platforms. | — |
| 8 | Fine Industries Contract manufacturer of high-quality fine chemicals for use in the Crop Protection, Pharmaceutical and… | $41M | 151 mo ago | 220 | 1977 | — | — | — |
| 9 | Ennogen Pharmaceutical and medical device company manufacturing API | $37M | 25 mo ago | — | 2011 | John Ruprai Founder & CEO | — | — |
| 10 | hVIVO Provider of clinical development, laboratory, and human challenge trial services | $31M | 93 mo ago | 133 | 1998 | John Oxford Founder | 18 patents Therapeutic compounds targeting cytokine storm and severe influenza, e.g., MAPK inhibitors | — |
| 11 | Chemoxy Contract manufacturer of intermediates | $31M | 135 mo ago | 150 | 1868 | — | — | 1 launch |
| 12 | MIP Discovery Provider of nanoparticle design, development & manufacturing services | $31M | 27 mo ago | 32 | 2015 | Stephane Argivier CEO | 3 patents Patents concentrated in computing, sensing & instrumentation | — |
| 13 | Mosaic Therapeutics Developer of targeted cancer combination therapies | $28M | 38 mo ago | 21 | 2020 | Mathew Garnett Co-Founder | — | — |
| 14 | Letoon Holding Biotech company producing medicinal oil | $25M | 31 mo ago | — | 2023 | Giuseppe Perla Co-Founder | — | — |
| 15 | Abingdon Health Developer of immunoassays for diagnostic purposes 57Funding top 29%Growth top 33%Market top 46%Moat top 48% All 7 signals ▾Fundingtop 29% Growthtop 33% Markettop 46% Moattop 48% Techbottom 49% Newsbottom 40% Globalbottom 32% Funding: Raised $24.1M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) Growth: Headcount 51 → 151 (+196%) across vintages · 2 acquisition/expansion moves in 24 mo rank vs industry peers · Fliar Intelligence Index 57/100 | $24M | 8 mo ago | 151 151 → 91 (-40%) · sector median +14% | 2008 | — | — | 2 awards |
| 16 | Lindus Health Provider of contract based clinical trial & recruitment services | $23M | 16 mo ago | 7 | 2021 | Michael Young Co-Founder & Co-CEO | — | — |
| 17 | Biofortuna Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services | $22M | 3 mo ago | 32 32 → 31 (-3%) · sector median +14% | 2008 | Katherine Douglas Co-Founder | 9 patents Molecular diagnostic reagents and kits for PCR amplification and tissue‑typing assays | — |
| 18 | Open Orphan Provider of testing vaccines & antivirals and CRO pharmaceutical services | $22M | 72 mo ago | 218 218 → 235 (+8%) · sector median +14% | 2017 | — | — | 1 award |
| 19 | TMC Provider of contract research and consulting services | $21M | 45 mo ago | 30 30 → 61 (+103%) · sector median +14% | 2001 | — | — | 1 job opening · 1 partnership |
| 20 | Seda Provider of consulting services to biopharma sector | $20M | 3 mo ago | — | 2015 | Paul Dickinson Founder and CSO | — | 2 job openings · 1 award |
| 21 | Mytos Provider of automated cell manufacturing for regenerative medicine applications | $19M | 32 mo ago | 19 | 2016 | Ignacio Willats Co-Founder | — | — |
| 22 | Discovery Biomed Contract research organization | $19M | 73 mo ago | 7 | 2007 | — | — | — |
| 23 | Thiakis Limited information available | $18M | 240 mo ago | 3 | 2004 | Bernard Poussot CEO | — | — |
| 24 | Cyprotex Predictive toxicology and in vitro and in silico ADME services provider | $17M | 89 mo ago | 17 | 1999 | — | — | 1 partnership |
| 25 | Trisk Provider of drug research & development services for pharmaceutical industry | $17M | 53 mo ago | 2 | 2020 | Gergo Bohner Co-Founder | — | 1 partnership |
| 26 | Panthera Clinical trials organization providing site management and patient recruitment services to pharmaceutical and… | $16M | 10 mo ago | 66 | 2019 | John Lyon Co-Founder & Chairman | 4 patents Provides modular support blocks for temporary construction hoarding systems | 1 award |
| 27 | Vectura Developer of inhaled therapeutics for respiratory diseases | $15M | 222 mo ago | 398 | 1997 | Will Downie CEO | 608 patents Inhalable respiratory drug formulations using glycopyrrolate and stearate excipients. | — |
| 28 | Prescient Healthcare Group Consulting services for product strategy and decision support | $13M | 24 mo ago | 217 | 2007 | Jamie Denison Pender CEO | — | 1 launch · 1 award |
| 29 | Beryllium Boutique service provider offering a range of solutions for drug discovery | $12M | 147 mo ago | 55 | 1999 | — | — | — |
| 30 | Liverpool ChiroChem Small organic molecule supplier for biotech/pharmaceutical R&D | $11M | 43 mo ago | 14 | 2014 | — | — | — |
| 31 | Metrion Biosciences CRO specializing in ion channel screening, cardiac safety profiling and drug discovery services | $8M | 29 mo ago | 48 | 2015 | — | 13 patents Design and synthesis of heterocyclic sulfonamide small‑molecule therapeutics | 1 job opening · 1 expansion |
| 32 | P1vital Provider of dug discovery & clinical trials services | $6M | 78 mo ago | — | 2004 | — | — | — |
| 33 | AWAKN CRO focused on early stage clinical trial research | $6M | 15 mo ago | 3 | 2020 | — | — | — |
| 34 | Maxwellia Provider of management services for pharmacies | $5M | 56 mo ago | 2 | 2013 | — | — | 1 award |
| 35 | Nexus BioQuest Provider of drug discovery services | $5M | 46 mo ago | 16 | 2022 | — | — | 1 job opening |
| 36 | Life Science People Provider of drug discovery, regulatory, marketing, staffing, and other services for biopharma sector | $5M | 34 mo ago | 17 | 2020 | — | — | — |
| 37 | SPARTA Biodiscovery Enabling nanoformulations for next-generation therapeutics through cutting-edge benchtop technology. | $4M | 32 mo ago | — | 2022 | Jelle Penders Chief Executive Officer | — | 1 launch |
| 38 | Gentronix Providr of in-vitro and in-vivo genetic toxicology screening services | $4M | 55 mo ago | 1 | 1999 | — | 18 patents Genotoxicity assessment of chemicals and pharmaceuticals using in vitro and in vivo assays | 2 job openings · 1 expansion |
| 39 | ConcR Provider of a platform predicting therapeutic response and outcome for cancer | $3M | 33 mo ago | 6 | 2018 | Matt Foster CEO | — | 1 partnership |
| 40 | Forge Genetics CRO focused on bioinformatics services | $3M | 8 mo ago | — | 2023 | Nigel Minton Co-Founder | 7 patents Design and production of synthetic nucleic acid therapeutics and gene‑editing constructs | 1 job opening |
| 41 | Exactmer CDMO focused on manufacturing of APIs | $3M | 39 mo ago | 24 24 → 22 (-8%) · sector median +14% | 2018 | Piers Gaffney Co-Founder | 15 patents Patents concentrated in chemistry & materials | — |
| 42 | ImmuONE CRO focused on innovative solutions for inhalation safety | $2M | 15 mo ago | 8 | 2019 | Abigail Martin Co-Founder & CEO | — | — |
| 43 | Clerkenwell Health CRO focused on conducting early stage clinical development of psychedelic medicines | $2M | 44 mo ago | 28 | 2020 | — | — | 4 job openings |
| 44 | GT LifeScience Provider of data science and engineering services to life sciences companies | $2M | 32 mo ago | — | 2020 | Andy Baynes Co-Founder & CEO | — | — |
| 45 | DeepMirror Provider of drug research & development, data analysis, and imaging services | $2M | 22 mo ago | 9 | 2019 | Ryan Greenhalgh Co-Founder and CTO | — | 1 launch · 1 partnership |
| 46 | Verisian Developer of clinical trial analysis solutions using traceability and AI | $1M | 33 mo ago | — | 2023 | Henning Kuich Co-Founder and CTO | — | — |
| 47 | PBR Life Sciences Provider of market research consulting services for life science sector | $1M | 17 mo ago | — | 2015 | Oluyinka Yinka Co-Founder | — | — |
| 48 | Magnitude Biosciences Provider of cell-free in vitro assay for drug discovery companies | $1M | 12 mo ago | 12 12 → 20 (+67%) · sector median +14% | 2018 | Fozia Saleem Chief Executive Officer | 2 patents Automated imaging and analysis systems for nematode behavior tracking | 1 partnership |
| 49 | Noumed Company specializes in manufacturing and marketing of generic pharmaceutical products | $915K | 31 mo ago | 91 | 2014 | — | — | — |
| 50 | stratosvir Developer of cancer treatment through viral immunotherapy | $262K | 24 mo ago | 3 | 2020 | — | 5 patents Engineering vaccinia virus vectors for enhanced vaccine delivery and immunogenicity | — |
Top 12 Biopharma Outsourcing companies in England
#1
Series A · Birkenhead, England · founded 2008 · 32 employees$21.6Mraised▾
Series A · Birkenhead, England · founded 2008 · 32 employees
Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Funding rounds
- Feb 2026Grant (prize money)$303.2K
- Mar 2021Series A—
- Aug 2018Series A$4.5M
- Jul 2017Series A$2.1M
Founders & team
Investors
Merseyside Special Investment Fund, Enterprise Ventures, Catapult Ventures, Foresight Group, Gov Wales, Mercia
Tech stack
Apache Http ServerCloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Font Api
#2
Series B · England · founded 2015$20Mraised▾
Series B · England · founded 2015
Provider of consulting services to biopharma sector
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers
Hiring: 2 hiring posts in 12 mo (public) · momentum +2 · hiring: Laboratory & Facilities Technician, Senior QC Scientist
Activity: 1 awards announced in 12 mo
Funding rounds
- Mar 2026Series B$20M
Founders & team
Investors
BGF
Tech stack
AutoptimizeCloudflareCloudflare Bot ManagementContact Form 7GodaddyGoogle Analytics
#3
Public · Oxford, England · founded 1995 · 815 employees$149.7Mraised▾
Public · Oxford, England · founded 1995 · 815 employees
Manufacturer of viral vectors for cell and gene therapy products. Services include process development, analytical methods, and manufacturing support for advanced therapy developers. Expertise spans lentivirus, adeno-associated virus, and adenovirus platforms to facilitate the development and production of therapeutic treatments.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 54k LinkedIn followers — 16.3% of this cohort's audience
Funding rounds
- Aug 2025Post IPO$81.3M
- Jan 2025Post IPO—
- Sep 2021Post IPO$68.3M
- Apr 2019Unattributed—
Founders & team
Investors
Briarwood Chase Management, Novo Holdings, Vitruvian Partners, Homology Medicines, WG Partners, Oxford University Innovation
Tech stack
Animate.CssApache Http ServerBeaver BuilderBootstrapCloudflareCloudflare Bot Management
#4
Public · York, England · founded 2008 · 151 employees$24.1Mraised▾
Public · York, England · founded 2008 · 151 employees
Developer of immunoassays for diagnostic purposes. It offers a rapid lateral flow immunoassay system that enables multiplexed immunodiagnostics. Its flagship product Seralite- FLC measures kappa (K) and lambda (λ) immunoglobulin-free light chain used for the detection of hematological cancers. It als provide research services for a range of sectors including the clinical point of care, clinical self-test, pharmaceutical, and others.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 29%Growth
top 33%Market
top 46%Moat
top 48%Tech
bottom 49%News
bottom 40%Funding: Raised $24.1M across 8 rounds · 8 rounds over 14 yrs (0.6/yr) · Last round Post IPO (Oct 2025)
Growth: Headcount 51 → 151 (+196%) across vintages · 2 acquisition/expansion moves in 24 mo · Fresh capital in last 24 mo
Market: 151 employees (top 12% of Life Sciences) · Top-10,000,000 web property
Audience (LinkedIn): 7k LinkedIn followers — 2.2% of this cohort's audience
Activity (LinkedIn): 2 awards announced in 12 mo
Funding rounds
- Oct 2025Post IPO$4.4M
- Jan 2019Series A$2.6M
- Dec 2017Series A$1.5M
- Jul 2016Series A$3.9M
Investors
Imperial Innovations, Mercia, IP Group, Northern Powerhouse Investment Fund
Tech stack
Apple Icloud MailCloudflareCloudflare Browser InsightsCookieyesGoogle AnalyticsGoogle Font Api
#5
Late Stage · Preston, England · founded 2019 · 66 employees$15.9Mraised▾
Late Stage · Preston, England · founded 2019 · 66 employees
Panthera Bio is a clinical trials organization that provides dedicated clinical trial sites in the UK, delivering clinical trials and patient recruitment services to pharmaceutical and contract research organizations. The company aims to transform the North Texas Biotechnology industry by offering efficient R&D and validation services, ensuring rapid development and accelerated timelines. With a focus on patient recruitment and site management, Panthera Bio supports the development of new medicines and treatments.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers
Activity: 1 awards announced in 12 mo
Funding rounds
- Aug 2025PE—
- Jul 2019Grant (prize money)$2M
- Jun 2019Grant (prize money)$600K
- May 2019Grant (prize money)$5.3M
Founders & team
Investors
HHS, LDC, Gresham House Ventures
#6
Series B · London, England · founded 2021 · 7 employees$23Mraised▾
Series B · London, England · founded 2021 · 7 employees
Provider of contract based clinical trial & recruitment services
LinkedIn Pulse recent public activity · Jul 2026
Audience: 18k LinkedIn followers — 5.5% of this cohort's audience
Funding rounds
- Jan 2025Series B$55M
- Aug 2023Series A$18M
- Jun 2023Seed—
- May 2023Grant (prize money)$543.1K
Founders & team
Investors
Ukri, Firstminute Capital, Presight Capital, Seedcamp, Amino Collective, Calm/Storm
Tech stack
Amazon S3Amazon Web ServicesApple Icloud MailChakra UiCloudflareCloudflare Bot Management
#7
Seed · Nottingham, England · founded 2023$3Mraised▾
Seed · Nottingham, England · founded 2023
CRO focused on bioinformatics services. It helps clients maintain their intellectual property while enabling high-precision gene knockouts and insertions. The company operates primarily as a contract research organization offering strain development services and aims to expand its technology into cell and gene therapy applications.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 1k LinkedIn followers
Hiring: 1 hiring post in 12 mo (public) · hiring: Operations Manager
Activity: 2 partnerships · 1 awards (incl. Forge Genetics) announced in 12 mo
Funding rounds
- Oct 2025Seed$2.7M
- Mar 2025Angel$305.5K
Founders & team
Investors
Mercia Ventures
Tech stack
BootstrapGoogle CloudGoogle Cloud CdnGoogle WorkspaceGsapHsts
#8
Acquired · Portishead, England · founded 2020 · 3 employees$5.9Mraised▾
Acquired · Portishead, England · founded 2020 · 3 employees
CRO focused on early stage clinical trial research
LinkedIn Pulse recent public activity · Jul 2026
Audience: 7k LinkedIn followers — 2.0% of this cohort's audience
Funding rounds
- Mar 2025Post IPO$141K
- Apr 2024Post IPO$95.9K
- Apr 2023Post IPO$575K
- Sep 2022Post IPO$1.9M
Investors
Palo Santo, Iter Investments
#9
Seed · Hatfield, England · founded 2019 · 8 employees$2.4Mraised▾
Seed · Hatfield, England · founded 2019 · 8 employees
ImmuONE is a biotech company specializing in innovative solutions for inhalation safety. They have developed the ImmuLUNG™ cell model, which helps predict how lung epithelial and immune cells react together. The company was established in April 2019 and is home to experienced scientists.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers
Funding rounds
- Mar 2025Seed$776.8K
- Oct 2023Seed$2.4M
Founders & team
Investors
Mercia, Midlands Engine Investment Fund, Pioneer Group
#10
Seed · Durham, England · founded 2018 · 12 employees$1Mraised▾
Seed · Durham, England · founded 2018 · 12 employees
Provider of cell-free in vitro assay for drug discovery companies. The services include pre screening of compounds, screening libraries of mutants, and screening compound libraries. It provides quantified non-invasive assays for health outcomes and drug discovery to biotech, nutrition, pharmaceutical, and academic sectors. Its services focus on areas such as aging, neurodegeneration, microbiome, toxicity, reproductive health, and disease modeling, using proprietary technology.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers
Activity: 1 partnerships (incl. Rejuvenate Bio) announced in 12 mo
Funding rounds
- May 2025Grant (prize money)—
- Mar 2025Seed$943.6K
- Oct 2022Seed$646.8K
- Aug 2020Seed$329.7K
Founders & team
Investors
Saker Capital, Northstar Ventures, Europa, Maven Capital Partners, Ukri, Northern Accelerator
#11
Funding Raised · Dartford, England · founded 2011$37.5Mraised▾
Funding Raised · Dartford, England · founded 2011
Ennogen is an international pharmaceutical and medical device company driven by an experienced management team. They specialize in pharmaceutical products and medical devices, with a focus on exporting their range of licensed products globally.
LinkedIn Pulse recent public activity · Jul 2026
Audience: 2k LinkedIn followers
Funding rounds
- May 2024Conventional Debt$37.5M
Founders & team
Investors
Santander
Tech stack
Alpine.JsApache Http ServerContact Form 7Google Font ApiMysqlOpen Graph
#12
Series A · London, England · founded 2021 · 92 employees$132.5Mraised▾
Series A · London, England · founded 2021 · 92 employees
Provider of drug research & development and clinical trial services for cell & gene therapeutic services
LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 4.1% of this cohort's audience
Funding rounds
- Mar 2023Series A$66.6M
Investors
Abingworth, Petrichor, DCVC, 4Bio Capital, Cathay Capital, Deerfield
Funding & investor landscape
$1.3Btotal disclosed funding
105companies funded
239disclosed rounds
0rounds last 90 days
Most active investors
Gov6 rounds
Notable founders
Katherine Douglas
Co-Founder · Biofortuna
Nanette Douglas
Co-Founder · Biofortuna
Paul Dickinson
Founder and CSO · Seda
Neill Mackenzie
Founder · Oxford BioMedica
Frank Mathias
CEO · Oxford BioMedica
John Lyon
Co-Founder & Chairman · Panthera
Stuart Young
CEO · Panthera
Michael Young
Co-Founder & Co-CEO · Lindus Health
Meri Beckwith
Co-Founder & Co-CEO · Lindus Health
Nigel Minton
Co-Founder · Forge Genetics
Chris Humphreys
Co-Founder & Chief Scientific Officer · Forge Genetics
Abigail Martin
Co-Founder & CEO · ImmuONE
Prism market signals · United Kingdom · country-scoped Prism corpus, 1,774,781 docs
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH FROM England · institutions
What England researches in biotechnology
University of New England, New England Biolabs, and Public Health England lead contested biotechnology research (stance 0.32) dominated by microbial interactions and livestock genetics, with concerns slightly outweighing breakthroughs.
28 papersstance +0.3231% breakthrough38% concern
local research themes
Animal Nutrition and PhysiologyBacteriophages and microbial interactionsGenetic and phenotypic traits in livestockRNA modifications and cancerNuts composition and effectsBacterial Genetics and Biotechnology
top institutions
- University of New England10
- New England Biolabs8
- Public Health England4
- Bank of England2
- Genomics England2
Common questions
How many Biopharma Outsourcing companies are there in England, United Kingdom?
Radar tracks 415 indexable Biopharma Outsourcing companies headquartered in England, United Kingdom that meet our profile-completeness bar.
What is the total funding raised by Biopharma Outsourcing companies in England, United Kingdom?
The Biopharma Outsourcing companies in England, United Kingdom on this list have raised a combined $1.3B in disclosed equity funding across 105 funded companies.
Which is the highest-funded Biopharma Outsourcing company in England, United Kingdom?
Oxford BioMedica is the highest-funded Biopharma Outsourcing company in England, United Kingdom, with $149.7M in disclosed equity funding.
How many Biopharma Outsourcing companies in England, United Kingdom are funded?
105 of the 415 Biopharma Outsourcing companies in England, United Kingdom on this list have disclosed at least one equity funding round.
How many Biopharma Outsourcing unicorns are there in England, United Kingdom?
None of the Biopharma Outsourcing companies in England, United Kingdom on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in England, United Kingdom Biopharma Outsourcing companies?
The most active investors in England, United Kingdom Biopharma Outsourcing companies on this list include Europa, Catapult Ventures, Mercia, Northern Powerhouse Investment Fund, Gov.
Riya SenguptaFinancials
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.